Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K6HE
|
|||
| Former ID |
DIB016569
|
|||
| Drug Name |
PRO-001
|
|||
| Synonyms |
PRO-001, ProRetina; Proinsulin (recombinant human protein, retinitis pigmentosa), ProRetina
Click to Show/Hide
|
|||
| Indication | Retinitis pigmentosa [ICD-11: 9B70; ICD-10: H35.5] | Phase 2 | [1] | |
| Company |
ProRetina Therapeutics SL
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Insulin-degrading enzyme (IDE) | Target Info | Modulator | [2] |
| KEGG Pathway | Alzheimer's disease | |||
| WikiPathways | Alzheimers Disease | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02520583) The Effects of Probiotic Supplementation on Markers of Muscle Damage and Performance Following Exercise Induced Muscle Damage. | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2371). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.